Long-Term Safety, Efficacy, and Quality of Life Outcomes With Adjunctive Brivaracetam Treatment at Individualized Doses in Patients With Epilepsy: An Up to 11-Year, Open-Label, Follow-Up Trial
Epilepsia - United Kingdom
doi 10.1111/epi.16484
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 28, 2020
Authors
Publisher
Wiley